Subscribe To
SLS / SELLAS Life Sciences to Participate in Upcoming Conferences in October 2021
SLS News
By GlobeNewsWire
October 17, 2023
SELLAS Life Sciences to Present Final Data from Phase 1/2 Study of Galinpepimut-S in Combination with Keytruda® (pembrolizumab) in Patients with WT1+ Platinum-Resistant Advanced Ovarian Cancer at the
NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS'' or the “Company”), a late-stage clinical b more_horizontal
By GlobeNewsWire
September 18, 2023
SELLAS Life Sciences to Participate in the Cantor Fitzgerald Global Healthcare Conference
NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS" or the “Company”), a late-stage clinical bio more_horizontal
By GlobeNewsWire
May 25, 2023
SELLAS Life Sciences to Present Phase 3 REGAL Trial in Progress Poster at 2023 ASCO Annual Meeting
NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical b more_horizontal
By Market Watch
February 24, 2023
Sellas Life Sciences raises $20 million from public offering of stock, warrants
Sellas Life Sciences Group Inc. SLS, -3.40% said Friday that it raised $20.0 million, through the public sale of common shares and warrants to buy sto more_horizontal
By InvestorPlace
February 24, 2023
Why Is SELLAS Life Sciences (SLS) Stock Down 38% Today?
SELLAS Life Sciences (NASDAQ: SLS ) stock is falling on Friday after the late-stage clinical biopharmaceutical company announced a proposed public off more_horizontal
By Benzinga
April 1, 2022
SELLAS Life Sciences Stock Plunges After $25M Capital Raise Via Equity, In-Licenses Cancer-Focused CDK9 Inhibitor
GenFleet Therapeutics has granted GFH009 rights to SELLAS Life Sciences Group Inc (NASDAQ: SLS) across all therapeutic and diagnostic uses worldwi more_horizontal
By GlobeNewsWire
October 7, 2021
SELLAS Life Sciences to Participate in Upcoming Conferences in October 2021
NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS" or the “Company”), a late-stage clinical bio more_horizontal
By GlobeNewsWire
October 7, 2021
SELLAS Life Sciences to Participate in Upcoming Conferences in October 2021
NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS" or the “Company”), a late-stage clinical bio more_horizontal